Global visual impairment market is projected to witness robust growth during 2025-2032. Visual impairment refers to a limitation in the ability to see caused due to diseases, disorders, or injuries which cannot be corrected by usual means like glasses. Some common causes of visual impairment include cataracts, glaucoma, age-related macular degeneration, and diabetic retinopathy among others. Rapidly aging global population, rising prevalence of diabetes, and urbanization are the key factors driving the global visual impairment market. However, high cost of treatment and lack of awareness in rural areas hinders the market growth. New innovations in treatments like stem cell therapy and gene therapy holds promise to treat conditions not addressable by conventional methods, thereby opening new avenues.
Market Dynamics:
The global visual impairment market is driven by the rapidly growing geriatric population which are more prone to eye diseases. As per UN, United Nations the number of people aged 60 years and older is expected to more than double by 2050 and reach nearly 2.1 billion. Rising prevalence of diabetes also fuels the market. According to IDF, 9.3% of the global adult population had diabetes in 2020 and it is projected to rise to 10.9% by 2045. Urbanization leads to unhealthy lifestyle habits like the overuse of digital devices which strains eyes and increases risk of myopia especially among the younger population. However, high cost of advanced treatments, limited healthcare access in remote areas, and lack of awareness hinders the market growth. Development of stem cell therapy and gene therapy to treat chronic eye conditions not addressable by traditional methods offers lucrative opportunities.
Key Features of the Study:
Detailed Segmentation-
Table of Contents
*Browse 32 market data tables and 28 figures on "Visual Impairment Market” - Global forecast to 2032
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients